Browse wiki
Jump to navigation
Jump to search
The following information was received fro … The following information was received from Washington State Department of Health:</br>This is notification of an event in Washington State as reported to or investigated by the WA Department of Health, Office of Radiation Protection.</br>STATUS: new</br>Licensee: Saint Mary Medical Center</br>City and State: Walla Walla, Washington</br>License Number: WN-M0101-1</br>Type of License: Medical Combination</br>Date of Event: September 7, 2004</br>Location of Event: Licensees facility in Walla Walla, Washington</br>ABSTRACT: (where, when, how, why; cause, contributing factors, corrective actions, consequences, Dept. of Health (DOH) on-site investigation; media attention): </br>The licensee's radiation safety officer notified the department that licensee staff had observed an anomaly after injecting a patient with Technetium (Tc) 99m, intended for a bone scan study. They had injected the proper patient with the apparent proper dose of 37.4 millicuries, Tc-99mHDP. When the patient returned approximately three hours later for the study, the patient showed no bone uptake but did have uptake in the liver and cardiac muscle. </br>Two unit doses were received on September 3rd from the nuclear pharmacy for two different patients. Both patients were injected on the same day. The second patient showed a nominal bone uptake and the study was performed per procedure. </br>The shipping documents and dose calibrator check indicated the dose was as ordered. The nuclear pharmacy was called and asked about the doses. The two doses had been drawn-up consecutively by the same pharmacist. The pharmacy was certain the order had been drawn, delivered and documented accurately. The licensee and pharmacy were unable to explain the anomalous first study. All information appears to corroborate that the study should have been as expected.</br>A repeat scan was performed. This dose localized as expected and the study gave diagnostic quality images.</br>On-site investigation by the department is not planned. </br>No media attention noted.</br>Notification Reporting Criteria: 10 CFR Part 35.33(a)</br>Isotope and Activity involved: Technetium (Tc) 99mHDP, 37.4 mCi </br>Overexposures? (number of workers/members of the public; dose estimate; body part receiving dose; consequence): Liver and Cardiac Muscle, dose estimate to be determined, the licensee indicated that the patient should receive adverse consequences as a result of the anomaly. </br>Lost, Stolen or Damaged? (mfg., model, serial number): N/A</br>Disposition/recovery: A second study was ordered and performed as expected. </br>Leak test? N/A</br>Vehicle: N/A </br>Release of activity? N/A</br>Activity and pharmaceutical compound intended: 37.4 mCi, Tc-99mHDP</br>Misadministered activity and/or compound received: (as far as could be determined) 37.4 mCi, Tc-99mHDP</br>Device (HDR, etc.) Mfg., Model; computer program: N/A</br>Exposure (intended/actual); consequences: It is anticipated that the patient will receive no adverse health effect from the anomalous dose. </br>Was patient or responsible relative notified? Both were notified.</br>Was written report provided? Yes, dated September 8, 2004.</br>Was referring physician notified? Yes</br>Consultant used? No</br>This event is assigned Washington event number WA-04-053 and is entered in NMED.t number WA-04-053 and is entered in NMED.
07:00:00, 7 September 2004 +
41,031 +
11:45:00, 9 September 2004 +
07:00:00, 7 September 2004 +
The following information was received fro … The following information was received from Washington State Department of Health:</br>This is notification of an event in Washington State as reported to or investigated by the WA Department of Health, Office of Radiation Protection.</br>STATUS: new</br>Licensee: Saint Mary Medical Center</br>City and State: Walla Walla, Washington</br>License Number: WN-M0101-1</br>Type of License: Medical Combination</br>Date of Event: September 7, 2004</br>Location of Event: Licensees facility in Walla Walla, Washington</br>ABSTRACT: (where, when, how, why; cause, contributing factors, corrective actions, consequences, Dept. of Health (DOH) on-site investigation; media attention): </br>The licensee's radiation safety officer notified the department that licensee staff had observed an anomaly after injecting a patient with Technetium (Tc) 99m, intended for a bone scan study. They had injected the proper patient with the apparent proper dose of 37.4 millicuries, Tc-99mHDP. When the patient returned approximately three hours later for the study, the patient showed no bone uptake but did have uptake in the liver and cardiac muscle. </br>Two unit doses were received on September 3rd from the nuclear pharmacy for two different patients. Both patients were injected on the same day. The second patient showed a nominal bone uptake and the study was performed per procedure. </br>The shipping documents and dose calibrator check indicated the dose was as ordered. The nuclear pharmacy was called and asked about the doses. The two doses had been drawn-up consecutively by the same pharmacist. The pharmacy was certain the order had been drawn, delivered and documented accurately. The licensee and pharmacy were unable to explain the anomalous first study. All information appears to corroborate that the study should have been as expected.</br>A repeat scan was performed. This dose localized as expected and the study gave diagnostic quality images.</br>On-site investigation by the department is not planned. </br>No media attention noted.</br>Notification Reporting Criteria: 10 CFR Part 35.33(a)</br>Isotope and Activity involved: Technetium (Tc) 99mHDP, 37.4 mCi </br>Overexposures? (number of workers/members of the public; dose estimate; body part receiving dose; consequence): Liver and Cardiac Muscle, dose estimate to be determined, the licensee indicated that the patient should receive adverse consequences as a result of the anomaly. </br>Lost, Stolen or Damaged? (mfg., model, serial number): N/A</br>Disposition/recovery: A second study was ordered and performed as expected. </br>Leak test? N/A</br>Vehicle: N/A </br>Release of activity? N/A</br>Activity and pharmaceutical compound intended: 37.4 mCi, Tc-99mHDP</br>Misadministered activity and/or compound received: (as far as could be determined) 37.4 mCi, Tc-99mHDP</br>Device (HDR, etc.) Mfg., Model; computer program: N/A</br>Exposure (intended/actual); consequences: It is anticipated that the patient will receive no adverse health effect from the anomalous dose. </br>Was patient or responsible relative notified? Both were notified.</br>Was written report provided? Yes, dated September 8, 2004.</br>Was referring physician notified? Yes</br>Consultant used? No</br>This event is assigned Washington event number WA-04-053 and is entered in NMED.t number WA-04-053 and is entered in NMED.
Has query"Has query" is a predefined property that represents meta information (in form of a <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Subobject">subobject</a>) about individual queries and is provided by <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Help:Special_properties">Semantic MediaWiki</a>.
00:00:00, 9 September 2004 +
WN-M0101-1 +
Modification date"Modification date" is a predefined property that corresponds to the date of the last modification of a subject and is provided by <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Help:Special_properties">Semantic MediaWiki</a>.
23:40:21, 24 November 2018 +
11:45:00, 9 September 2004 +
2.198 d (52.75 hours, 0.314 weeks, 0.0723 months) +
07:00:00, 7 September 2004 +
Stolen + and Overexposure +
URL"URL" is a <a href="/Special:Types/URL" title="Special:Types/URL">type</a> and predefined property provided by <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Help:Special_properties">Semantic MediaWiki</a> to represent URI/URL values.